Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.270
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
4.390
+0.120 (2.80%)
After-hours: Dec 5, 2025, 7:18 PM EST
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $22.96 million as of December 5, 2025.
Market Cap
22.96M
Enterprise Value
9.43M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.27
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $22.96M, an increase of 112.82%. That is a compound annual growth rate of 122.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 22.96M | 311.38% |
| Dec 31, 2024 | 5.58M | -48.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |